Preparing your experience, please wait…
K
Guidelines & protocols
NEWER PHARMACOLOGIC TREATMENTS IN ADULTS WITH TYPE 2 DIABETES: A CLINICAL GUIDELINE FROM THE AMERICAN COLLEGE OF PHYSICIANS
American College of Physicians
PDF11 pages350 KB
The American College of Physicians developed this clinical guideline to provide updated recommendations on the use of newer pharmacologic treatments for type 2 diabetes. It is based on a systematic review of the effectiveness and harms of various treatment options, including SGLT-2 inhibitors and GLP-1 agonists. The guideline emphasizes the importance of considering patient values, preferences, and costs when making treatment decisions. Recommendations include the use of SGLT-2 inhibitors or GLP-1 agonists as add-on therapies for patients with inadequate glycemic control.
No account needed
Discuss clinical evidence & guidelines
Examine in Ask OslerAsk this resource
Answers from this document onlyMore like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
Standards of Care in Diabetes 2026
Same clinical topic · Endocrinology
RETINOPATHY, NEUROPATHY, AND FOOT CARE: STANDARDS OF CARE IN DIABETES—2026
Same clinical topic · Endocrinology
6. GLYCEMIC GOALS, HYPOGLYCEMIA, AND HYPERGLYCEMIC CRISES: STANDARDS OF CARE IN DIABETES—2026
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology